1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018;68(6):394-424 doi 10.3322/caac.21492.
2. SEER Cancer Statistics Review.<https://seer.cancer.gov/statfacts/html/colorect.html>.
3. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104(1):66-73 doi 10.7326/0003-4819-104-1-66.
4. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993;269(10):1262-7.
5. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003;95(3):230-6 doi 10.1093/jnci/95.3.230.
6. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007;132(7):2304-12 doi 10.1053/j.gastro.2007.03.030.
7. Lansdorp-Vogelaar I, Goede SL, Bosch LJW, Melotte V, Carvalho B, van Engeland M, et al. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening. Clin Gastroenterol Hepatol 2018;16(4):504-12 e11 doi 10.1016/j.cgh.2017.07.011.
8. Nicholson FB, Korman MG. Acceptance of flexible sigmoidoscopy and colonoscopy for screening and surveillance in colorectal cancer prevention. J Med Screen 2005;12(2):89-95 doi 10.1258/0969141053908294.
9. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58(3):130-60 doi 10.3322/CA.2007.0018.
10. Rodrigues-Pinto E, Ferreira-Silva J, Macedo G, Rex DK. (Technically) Difficult colonoscope insertion - Tips and tricks. Dig Endosc 2019 doi 10.1111/den.13465.
11. Tkach M, Thery C. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell 2016;164(6):1226-32 doi 10.1016/j.cell.2016.01.043.
12. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. Journal of molecular medicine (Berlin, Germany) 2013;91(4):431-7 doi 10.1007/s00109-013-1020-6.
13. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010;285(23):17442-52 doi 10.1074/jbc.M110.107821.
14. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015;527(7578):329-35 doi 10.1038/nature15756.
15. An T, Qin S, Xu Y, Tang Y, Huang Y, Situ B, et al. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. Journal of Extracellular Vesicles 2015;4(1):1-15 doi 10.3402/jev.v4.27522.
16. Jingushi K, Uemura M, Ohnishi N, Nakata W, Fujita K, Naito T, et al. Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin. Int J Cancer 2018;142(3):607-17 doi 10.1002/ijc.31080.
17. Okuda S, Watanabe Y, Moriya Y, Kawano S, Yamamoto T, Matsumoto M, et al. jPOSTrepo: an international standard data repository for proteomes. Nucleic Acids Res 2017;45(D1):D1107-D11 doi 10.1093/nar/gkw1080.
18. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological) 1995;57(1):289-300 doi 10.1111/j.2517-6161.1995.tb02031.x.
19. Lässer C, Eldh M, Lötvall J. Isolation and Characterization of RNA-Containing Exosomes. Journal of Visualized Experiments 2012(59):1-6 doi 10.3791/3037.
20. Carpentier G, Martinelli M, Courty J, Cascone I. Angiogenesis Analyzer for ImageJ. 4th ImageJ User and Developer Conference proceedings, Mondorf-les-Bains, Luxembourg 2012:198-201.
21. Saigusa D, Okamura Y, Motoike IN, Katoh Y, Kurosawa Y, Saijyo R, et al. Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery. PLoS One 2016;11(8):e0160555 doi 10.1371/journal.pone.0160555.
22. Hishinuma E, Narita Y, Saito S, Maekawa M, Akai F, Nakanishi Y, et al. Functional Characterization of 21 Allelic Variants of Dihydropyrimidine Dehydrogenase Identified in 1070 Japanese Individuals. Drug Metab Dispos 2018;46(8):1083-90 doi 10.1124/dmd.118.081737.
23. Zhu B, Wei H, Wang Q, Li F, Dai J, Yan C, et al. A simultaneously quantitative method to profiling twenty endogenous nucleosides and nucleotides in cancer cells using UHPLC-MS/MS. Talanta 2018;179:615-23 doi 10.1016/j.talanta.2017.11.054.
24. Lu Y, Wang W, Wang J, Yang C, Mao H, Fu X, et al. Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue. PLoS One 2013;8(9):e73866 doi 10.1371/journal.pone.0073866.
25. Fukumura D, Jain RK. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 1998;17(1):77-89 doi 10.1023/a:1005908805527.
26. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90(8):587-96 doi 10.1093/jnci/90.8.587.
27. Kim YH, Hwang JH, Kim KS, Noh JR, Gang GT, Seo Y, et al. NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats. Am J Hypertens 2015;28(1):50-7 doi 10.1093/ajh/hpu116.
28. Crabtree MJ, Hale AB, Channon KM. Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency. Free Radic Biol Med 2011;50(11):1639-46 doi 10.1016/j.freeradbiomed.2011.03.010.
29. Klatt P, Schmidt K, Werner ER, Mayer B. Determination of nitric oxide synthase cofactors: heme, FAD, FMN, and tetrahydrobiopterin. Methods Enzymol 1996;268:358-65 doi 10.1016/s0076-6879(96)68038-0.
30. Gao L, Pung YF, Zhang J, Chen P, Wang T, Li M, et al. Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 2009;297(1):H331-9 doi 10.1152/ajpheart.00007.2009.
31. Abdelmagid SA, Rickard JA, McDonald WJ, Thomas LN, Too CK. CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines. J Cell Biochem 2011;112(4):1084-92 doi 10.1002/jcb.23022.
32. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor- induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998;273(36):23504-8 doi 10.1074/jbc.273.36.23504.
33. Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J Mol Biol 2016;428(4):688-92 doi 10.1016/j.jmb.2015.09.019.
34. Jingushi K, Uemura M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, et al. Leukocyteassociated immunoglobulinlike receptor 1 promotes tumorigenesis in RCC. Oncol Rep 2019;41(2):1293-303 doi 10.3892/or.2018.6875.
35. Chen H, Chen XZ, Waterboer T, Castro FA, Brenner H. Viral infections and colorectal cancer: a systematic review of epidemiological studies. Int J Cancer 2015;137(1):12- 24 doi 10.1002/ijc.29180.
36. Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med 2018;7(1):14 doi 10.1186/s40169-018-0192-7.
37. Chen Y, Tang Y, Fan GC, Duan DD. Extracellular vesicles as novel biomarkers and pharmaceutic targets of diseases. Acta Pharmacol Sin 2018;39(4):499-500 doi 10.1038/aps.2018.15.
38. Rotmann A, Strand D, Martine U, Closs EI. Protein kinase C activation promotes the internalization of the human cationic amino acid transporter hCAT-1. A new regulatory mechanism for hCAT-1 activity. J Biol Chem 2004;279(52):54185-92 doi 10.1074/jbc.M409556200.
39. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). The Journal of membrane biology 2006;213(2):67-77 doi 10.1007/s00232-006-0875-7.
40. Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr 2004;24:377-99 doi 10.1146/annurev.nutr.23.011702.073120.
41. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the ""arginine paradox"". J Biol Chem 1997;272(50):31213-6 doi 10.1074/jbc.272.50.31213.
42. Denninger JW, Marletta MA. Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411(2-3):334-50 doi 10.1016/s0005- 2728(99)00024-9.
43. Yoshizuka N, Chen RM, Xu Z, Liao R, Hong L, Hu WY, et al. A novel function of p38- regulated/activated kinase in endothelial cell migration and tumor angiogenesis. Mol Cell Biol 2012;32(3):606-18 doi 10.1128/MCB.06301-11.
44. Rousseau S, Houle F, Landry J, Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997;15(18):2169-77 doi 10.1038/sj.onc.1201380.